Maro Ohanian DO

13PUBLICATIONS
44CO-AUTHORS
Haematological tumoursRegenerative medicine (incl. stem cells)Cancer therapy (excl. chemotherapy and radiation therapy)Medical mycologyHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 02, 2022
Retrospective comparison of survival and responses to Fludarabine, Cytarabine, GCSF (FLAG) in combination with gemtuzumab ozogamicin (GO) or Idarubicin (IDA) in patients with newly diagnosed core binding factor (CBF) acute myelogenous leukemia: MD Anderson experience in 174 patients.

Gautam Borthakur, Farhad Ravandi, Keyur Patel

|Jun 17, 2022
Blinatumomab is associated with favorable outcomes in patients with B-cell lineage acute lymphoblastic leukemia and positive measurable residual disease at a threshold of 10-4 and higher.

Elias J Jabbour, Nicholas J Short, Nitin Jain

|Jun 15, 2022
Phase II Study of Venetoclax Added to Cladribine Plus Low-Dose Cytarabine Alternating With 5-Azacitidine in Older Patients With Newly Diagnosed Acute Myeloid Leukemia.

Tapan M Kadia, Patrick K Reville, Xuemei Wang

|Feb 12, 2022
Activity of decitabine as maintenance therapy in core binding factor acute myeloid leukemia.

Jayastu Senapati, Mahran Shoukier, Guillermo Garcia-Manero

|Nov 08, 2021
Freeze-dried platelets are a promising alternative in bleeding thrombocytopenic patients with hematological malignancies.

Maro Ohanian, Jose A Cancelas, Robertson Davenport

|Apr 23, 2021
FLT3 inhibitor based induction and allogeneic stem cell transplant in complete remission 1 improve outcomes in patients with newly diagnosed Acute Myeloid Leukemia with very low FLT3 allelic burden.

Musa Yilmaz, Naval Daver, Gautam Borthakur

Pageof 3

Frequent Collaborators

10 joint publications

Tapan M Kadia

8 joint publications

Elias Jabbour

8 joint publications

Naval G Daver

6 joint publications

Nicholas J Short